BioXcel Therapeutics (BTAI) Reports Completion of Patient Enrollment in Phase 3 SERENITY Trials with BXCL501

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. ACN
6. AZN
7. ROIV
8. AAPL
9. QCOM
10. NVDA

Go back to BioXcel Therapeutics (BTAI) Reports Completion of Patient Enrollment in Phase 3 SERENITY Trials with BXCL501
(NASDAQ: BTAI) Delayed: 0.07 --0 (-0%)
Previous Close $0.07    52 Week High $ 
Open $0.07    52 Week Low $ 
Day High $0.07    P/E N/A 
Day Low $0.07    EPS $ 
Volume 9,277,777